Toxic epidermal necrolysis associated with combination therapy of spironolactone and torsemide

Journal Title: Journal of Pharmacovigilance and Drug Research - Year 2020, Vol 1, Issue 20201105

Abstract

Dytor plus tablet is a fixed-dose combination of torsemide and spironolactone used for generalized edema. TEN is a serious, potentially life-threatening dermatological disorder. Here we present a case report of a 47-year-old female who was on Dytor Plus (5/50 mg)therapy once daily for generalized edema; presented to dermatology outpatient department with chief complaints of multiple erosions over oral cavity, swelling of lips with scaling, redness and burning sensation in both eyes, multiple well defined mostly erythematous rashes over the entire body since 2 days .on examination, her vital signs were stable and lab result indicate she had elevated SGOT(140 IU/L), SGPT (228 IU/L), ALP (162IU/L) and blood urea(47 mg/ml) values. The patient was diagnosed to have developed Dytor plus induced toxic epidermal necrolysis. Discontinued the medicine and prescribed with Dexamethasone injection, IgG Injection, Cefotaxime injection, Cloxacilline capsule, Cetirizine tablet, Hydroxypropyl methylcellulose eye drop, and candid mouth paint. The patient had a hospital stay of 25 days. The patient improved symptomatically. Causality was assessed as per the WHO-UMC causality scale and this case was put in the probable category. This case was uploaded via vigiflow under the pharmacovigilance programme of India having report Id 2019-30695.

Authors and Affiliations

Melcy Mary Philip 1*, Kala Kesavan P 1, Jai Prakash 2

Keywords

Related Articles

Risk-benefit associated with Azithromycin: A brief review

Azithromycin is the most popular prescribed antimicrobial agent around the world. It comes under the class of macrolide antibiotics. Because of its higher efficacy, tolerance, and broad-spectrum activity, it is primarily...

Artificial Neural Network: A Data Mining Tool in Pharmacovigilance

Pharmacovigilance ensures patients safety as well as drug safety. In India, there is still a lot to be done and learned to ensure that the work and activities done in the area of pharmacovigilance are safely implemented....

Design, synthesis, characterization and in vivo studies of some hydroxylated chalcone derivatives as hypoglycemic agents

Low molecular weight ligands (LMWL) have citadel reputation in the modulation of numerous therapeutic targets as a result of their smart uniqueness. The hydroxylated chalcone derivatives have been reported to be therapeu...

A Review on Potential Drug Delivery System as a Treatment of Intercellular Bacterial Infection

Intracellular bacterial pathogens are hard to treat because of the inability of conventional antimicrobial agents belonging to widely used classes, like aminoglycosides and β-lactams, fluoroquinolones, or macrolides to p...

Cutaneous Adverse Drug Reactions in a Tertiary Care Hospital: An Observational Study

Cutaneous adverse drug reactions (CADRs) are one of the most common ADRs caused by drugs causing a lot of morbidity and mortality. The overall incidence of CADRs in developed countries is 1-3 %, while that in the develop...

Download PDF file
  • EP ID EP690855
  • DOI 10.5281/zenodo.4016769
  • Views 169
  • Downloads 0

How To Cite

Melcy Mary Philip 1*, Kala Kesavan P 1, Jai Prakash 2 (2020). Toxic epidermal necrolysis associated with combination therapy of spironolactone and torsemide. Journal of Pharmacovigilance and Drug Research, 1(20201105), -. https://europub.co.uk./articles/-A-690855